Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 8/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.65 |
| ▸ | MEN1 | O00255 | 7/20 | 0.65 |
| ▸ | MAPT | P10636 | 5/20 | 0.65 |
| ▸ | RGS12 | O14924 | 3/20 | 0.65 |
| ▸ | RECQL | P46063 | 3/20 | 0.65 |
| ▸ | THRB | P10828 | 2/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | PARP1 | P09874 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.65 |
| ▸ | APEX1 | P27695 | 1/20 | 0.65 |
| ▸ | CASP1 | P29466 | 1/20 | 0.65 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.65 |
| ▸ | MTOR | P42345 | 1/20 | 0.65 |
| ▸ | BLM | P54132 | 1/20 | 0.65 |
| ▸ | CASP7 | P55210 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30516566 | 1.00 | USP2 (0.65) | USP2KMT2AMEN1MAPTRGS12 | |
| SCHEMBL29556131 | 1.00 | USP2 (0.65) | USP2KMT2AMEN1MAPTRGS12 | |
| SCHEMBL12874092 | 0.83 | KEAP1 (0.69) | USP2KMT2AMEN1MAPTRGS12 | |
| SCHEMBL10267341 | 0.83 | TYMS (0.70) | USP2KMT2AMEN1MAPTRGS12 | |
| SCHEMBL1133922 | 0.79 | TYMS (0.51) | USP2KMT2AMEN1MAPTRGS12 | |
| SCHEMBL503227 | 0.79 | KEAP1 (1.00) | USP2KMT2AMEN1MAPTRGS12 | |
| SCHEMBL9797387 | 0.79 | TYMS (0.48) | USP2KMT2AMEN1MAPTRGS12 | |
| SCHEMBL29941362 | 0.78 | KMT2A (1.00) | USP2KMT2AMEN1MAPTRGS12 | |
| SCHEMBL21124 | 0.78 | KMT2A (1.00) | USP2KMT2AMEN1MAPTRGS12 | |
| SCHEMBL19911015 | 0.78 | TYMS (0.63) | USP2KMT2AMEN1MAPTRGS12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 390 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115215997-B | Polyester resin for high-hardness matt powder coating and preparation method thereof | 黄山市源润新材料科技有限公司 | 2024-01-23 | — | — | CN | claimed |
| CN-117164855-A | High-cohesiveness branched polyimide polymer and preparation method thereof | 江苏环峰电工材料有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-116790178-B | Corrosion-resistant aqueous epoxy resin coating and preparation method thereof | 广州恒峰新材料科技有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-116790178-A | Corrosion-resistant aqueous epoxy resin coating and preparation method thereof | 广州恒峰新材料科技有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-114426519-B | Fluorescent probe NI-CO-CYS for cystathionine beta lyase detection | 中国科学院大连化学物理研究所 | 2023-09-12 | — | — | CN | claimed |
| CN-114874722-B | Moisture-heat-resistant epoxy conductive adhesive, preparation method and application thereof | 东莞市德聚胶接技术有限公司 | 2023-01-10 | — | — | CN | claimed |
| CN-115215997-A | Polyester resin for high-hardness and matt powder coating and preparation method thereof | 黄山市源润新材料科技有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-115197141-A | Fluorescent probe NI-CO-HCYS for cystathionine gamma lyase detection | 中国科学院大连化学物理研究所 | 2022-10-18 | — | — | CN | claimed |
| CN-114874722-A | Moisture-heat-resistant epoxy conductive adhesive, preparation method and application thereof | 东莞市德聚胶接技术有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-114426519-A | Fluorescent probe NI-CO-CYS for cystathionine beta lyase detection | 中国科学院大连化学物理研究所 | 2022-05-03 | — | — | CN | claimed |
| US-20040215002-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040215038-A1 | Colorant precursor compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040214918-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-6790267-B1 | METHINE COLORANT COMPOUNDS FOR PHASE CHANGE INKS | XEROX CORPORATION | 2004-09-14 | — | — | US | claimed |
| US-6764541-B1 | Colorant compositions | XEROX CORPORATION | 2004-07-20 | — | — | US | claimed |
| EP-0515379-A4 | ELECTRO-BLOTTING OF ELECTROPHORETICALLY RESOLVED FLUORESCENT-LABELED SACCHARIDES AND DETECTION OF ACTIVE STRUCTURES WITH PROTEIN PROBES | GLYCOMED INC (US) | 1994-09-14 | — | — | EP | claimed |
| EP-0515379-A1 | ELECTRO-BLOTTING OF ELECTROPHORETICALLY RESOLVED FLUORESCENT-LABELED SACCHARIDES AND DETECTION OF ACTIVE STRUCTURES WITH PROTEIN PROBES | GLYCOMED INCORPORATED (US) | 1992-12-02 | — | — | EP | claimed |
| US-5094740-A | TWO-DIMENSIONAL ELECTROPHORETIC SEPARATION OF CARBOHYDRATES | GLYCOMED, INC. (US) | 1992-03-10 | — | — | US | claimed |
| WO-1991012276-A1 | ELECTRO-BLOTTING OF ELECTROPHORETICALLY RESOLVED FLUORESCENT-LABELED SACCHARIDES AND DETECTION OF ACTIVE STRUCTURES WITH PROTEIN PROBES | GLYCOMED INCORPORATED (US) | 1991-08-22 | — | — | WO | claimed |
| WO-1991012275-A1 | TWO-DIMENSIONAL ELECTROPHORETIC SEPARATION OF CARBOHYDRATES | GLYCOMED INCORPORATED (US) | 1991-08-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040215038-A1 | Colorant precursor compositions | RB1, SULT1A1, CBR1 | USP2 3646/4885KMT2A 585/4885MEN1 3742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.